Cingulate Inc. (NASDAQ:CING) Financings

Cingulate Inc.

Financings

RaiseDate
Private placement of preferred stock and warrants (PIPE)
Closed: US$12M raised · US$5.04 a share · 80% warrant coverage; warrants exercisable upon stockholder approval; three-year term
Buyers: Falcon Creek Capital Advisor LLC (Affiliates led the PIPE; received right to designate up to two board members); Jeff Hargroves (significant participant in the PIPE financing)
Insiders: The transaction included insider participation; former board member and board designee Jeff Hargroves was a significant participant.
Use of proceeds: General operations ahead of the commercial launch of CTx-1301, subject to FDA approval
Feb 17, 2026
Non-convertible, unsecured promissory note
Closed: US$6M raised
Use of proceeds: Working capital and other general corporate purposes
Nov 10, 2025
Non-convertible, unsecured promissory note
Closed: US$5M raised
Use of proceeds: Working capital and other general corporate purposes
Dec 23, 2024

Read by 6ix AI from the company's releases